MTI Regulatory Roundup: global medical device regulatory update
Global look at regulatory compliance, guidance, trends and deadlines.
Global look at regulatory compliance, guidance, trends and deadlines.
The FDA announced the TEMPO pilot, an approach to encourage the use of digital technologies that meet people where they are. The pilot supports innovative tools and a health care delivery model that could improve care for millions of Americans managing chronic disease.
The collaboration aims to deliver real-time image processing, robotic control and cloud-enabled intelligence in a unified architecture.
Trial will evaluate the safety and effectiveness of the AtriCure Isolator® Synergy™ EnCompass® clamp and AtriClip® Left Atrial Appendage Exclusion System to reduce the occurrence of new-onset atrial fibrillation in cardiac surgery patients.
Acquisition is expected to strengthens Thermo Fisher’s position in delivering clinical information to pharma and biotech customers.
Transaction Expected to Help Hologic Strengthen its Leadership in Women’s Health and Accelerate Growth
Survey will assess demographics, salary rates, more.
AMA CEO says, “Augmented Intelligence will be a defining force in the future of health care, but right now we are barely scratching the surface of its potential.”
Asset acquisition expected to expand Merit’s Endoscopy portfolio with an innovative device to treat patients suffering from Barretts esophagus and other gastrointestinal disorders.
Boston Sci acquisition expected to expand the neuromodulation offerings for people living with chronic pain.